High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.8M
$3,800,166
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2026-03-31 | $16,750 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-31 | $569,085 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2026-03-30 | $16,750 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-30 | $559,230 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2026-01-30 | $16,750 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-01-30 | $708,946x2 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2026-01-29 | $16,750x2 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-01-29 | $734,582x2 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2025-10-02 | $16,750 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-02 | $615,668 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2025-10-01 | $16,750 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-01 | $612,655 | S | Form 4 |